EXHIBIT 8
Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries and joint ventures as of March 31, 2022:
| Name of the subsidiary/joint venture | Country of Incorporation | Percentage of Direct/Indirect Ownership Interest |
| Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. | Malaysia | 100%(3) |
| Aurigene Discovery Technologies Limited | India | 100% |
| Aurigene Pharmaceutical Services Limited (from September 16, 2019) | India | 100%(3) |
| beta Institut gemeinnützige GmbH | Germany | 100%(8) |
| betapharm Arzneimittel GmbH | Germany | 100%(8) |
| Cheminor Investments Limited | India | 100% |
| Cheminor Employees Welfare Trust | India | Refer to below footnote(15) |
| Chirotech Technology Limited | United Kingdom | 100%(2)(5) |
| Dr. Reddy’s Research Foundation | India | Refer to below footnote(15) |
| Dr. Reddy's Employees ESOS Trust | India | Refer to below footnote(15) |
| Dr. Reddy’s Farmaceutica Do Brasil Ltda. | Brazil | 100% |
| Dr. Reddy’s Laboratories (EU) Limited | United Kingdom | 100%(10) |
| Dr. Reddy’s Laboratories (Proprietary) Limited | South Africa | 100%(10) |
| Dr. Reddy’s Laboratories (UK) Limited | United Kingdom | 100%(5) |
| Dr. Reddy’s Laboratories Canada, Inc. | Canada | 100%(10) |
| Dr. Reddy's Laboratories Chile SPA. | Chile | 100%(10) |
| Dr. Reddy’s Laboratories, Inc. | U.S.A. | 100%(10) |
| Dr. Reddy’s Laboratories Japan KK | Japan | 100%(10) |
| Dr. Reddy’s Laboratories Kazakhstan LLP | Kazakhstan | 100%(10) |
| Dr. Reddy’s Laboratories Louisiana, LLC | U.S.A. | 100%(6) |
| Dr. Reddy’s Laboratories Malaysia Sdn. Bhd. | Malaysia | 100%(10) |
| Dr. Reddy’s Laboratories New York, LLC | U.S.A. | 100%(1) |
| Dr. Reddy’s Laboratories Philippines Inc. | Philippines | 100%(10) |
| Dr. Reddy’s Laboratories Romania S.R.L. | Romania | 100%(10) |
| Dr. Reddy’s Laboratories SA | Switzerland | 100% |
| Dr. Reddy’s Laboratories Taiwan Limited | Taiwan | 100%(10) |
| Dr. Reddy’s Laboratories (Thailand) Limited | Thailand | 100%(10) |
| Dr. Reddy’s Laboratories, LLC | Ukraine | 100%(10) |
| Dr. Reddy’s New Zealand Limited | New Zealand | 100%(10) |
| Dr. Reddy’s S.R.L. | Italy | 100%(11) |
| Dr. Reddy’s Bio-Sciences Limited | India | 100% |
| Dr. Reddy’s Laboratories (Australia) Pty. Limited | Australia | 100%(10) |
| Dr. Reddy’s Laboratories S.A.S. | Colombia | 100%(10) |
| Dr. Reddy’s Research and Development B.V. | Netherlands | 100%(12) |
| Dr. Reddy’s Venezuela, C.A. | Venezuela | 100%(10) |
| Dr. Reddy’s (WUXI) Pharmaceutical Company Limited | China | 100%(2)(10) |
| Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited (from August 19, 2020) | China | 100%(10) |
| DRES Energy Private Limited | India | 26%(14) |
| DRL Impex Limited | India | 100%(13) |
| Dr. Reddy’s Laboratories B.V. | Netherlands | 100%(12) |
| Dr. Reddy’s Formulations Limited (from March 11, 2021) | India | 100% |
| Idea2Enterprises (India) Private Limited | India | 100% |
| Imperial Credit Private Limited | India | 100% |
| Industrias Quimicas Falcon de Mexico, S.A. de CV | Mexico | 100% |
| Kunshan Rotam Reddy Pharmaceutical Co. Limited | China | 51.33%(4) |
| Lacock Holdings Limited | Cyprus | 100%(10) |
| Nimbus Health, GmbH (from February 24, 2022) | Germany | 100%(8) |
| Dr. Reddy’s Laboratories LLC | Russia | 100%(10) |
| DRS LLC | Russia | 100%(9) |
Organizational structure (continued)
| Name of the subsidiary/joint venture | Country of Incorporation | Percentage of Direct/Indirect Ownership Interest |
| Promius Pharma, LLC | U.S.A. | 100%(6) |
| Reddy Holding GmbH | Germany | 100%(10) |
| Reddy Netherlands B.V. | Netherlands | 100%(10) |
| Reddy Pharma Iberia S.A.U. | Spain | 100%(10) |
| Reddy Pharma Italia S.R.L. | Italy | 100%(7) |
| Reddy Pharma SAS | France | 100%(10) |
| Svaas Wellness Limited | India | 100% |
Aurigene Discovery Technologies, Inc. | U.S.A. | 100%(3)(16) |
DRANU LLC | U.S.A. | 50%(17) |
| (1) | Indirectly owned through Dr. Reddy’s Laboratories, Inc. (from October 29, 2020), formerly a subsidiary of Dr. Reddy’s Laboratories SA. Also, conversion from corporation to limited liability company is effective October 30, 2020. |
| (2) | Entity under liquidation. |
| (3) | Indirectly owned through Aurigene Discovery Technologies Limited. |
| (4) | Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary as per Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements. |
| (5) | Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited. |
| (6) | Indirectly owned through Dr. Reddy’s Laboratories Inc. |
| (7) | Indirectly owned through Lacock Holdings Limited. |
| (8) | Indirectly owned through Reddy Holding GmbH. |
| (9) | Indirectly owned through Dr. Reddy’s Laboratories LLC, Russia. |
| (10) | Indirectly owned through Dr. Reddy’s Laboratories SA. |
| (11) | Indirectly owned through Reddy Pharma Italia S.R.L. |
| (12) | Indirectly owned through Reddy Netherlands B.V. |
| (13) | Indirectly owned through Idea2Enterprises (India) Pvt. Limited. |
| (14) | Accounted in accordance with IFRS 11, “Joint Arrangements”. |
| (15) | The Company does not have any equity interests in this entity, but has significant influence or control over it. |
| (16) | Liquidated on March 23, 2022. |
| (17) | Pursuant to the sale of the membership interests in DRANU, LLC, it ceased to be a joint venture effective March 31, 2021. |